Phase 1 Study of Treatment for Advanced HER2-Positive Cancers Gets Underway
News
A Phase 1 clinical trial assessing the safety and efficacy of the anti-HER2 antibody ZW25 in advanced or metastatic HER2-positive cancers has just dosed its first patient, according to a recent ... Read more